(1R,3S)-3-(5-(3-(甲氧基甲基)-1-甲基-1H-吡唑-5-甲酰胺基)-1H-吡唑-3-基)环戊基异丙基氨基甲酸酯
Tagtociclib (PF-07104091)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Tagtociclib (PF-07104091)
CAS2460249-19-6
FormulaC19H28N6O4
MW404.46
AppearanceSolid powder
Storage conditionDry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
Security information
Product details

Tagtociclib, also known as PF-07104091, is an orally bioavailable inhibitor of cyclin-dependent kinase 2 (CDK2), with potential antineoplastic activity. Upon administration, CDK2 inhibitor PF-07104091 selectively targets, binds to and inhibits the activity of CDK2. This may lead to cell cycle arrest, the induction of apoptosis, and the inhibition of tumor cell proliferation. CDKs are serine/threonine kinases that are important regulators of cell cycle progression and cellular proliferation and are frequently overexpressed in tumor cells. CDK2/cyclin E complex plays an important role in retinoblastoma (Rb) protein phosphorylation and the G1-S phase cell cycle transition. CDK2/cyclin A complex plays an important role in DNA synthesis in S phase and the activation of CDK1/cyclin B for the G2-M phase cell cycle transition.

Related literature
Related
Sorry, no related items
History
Tagtociclib (PF-07104091)